Infertility is one of the major concerns in the world. One out of six couples in the world suffers from some form of infertility. About 10% women aged 20-44 suffer from infertility. There are various causes for infertility which include physiological (20-30% cases), some cases include genetically induced disorders whereas sometimes it may be self induced as in case of contraceptive surgeries. The market is driven by rising awareness amongst couples, a strong and developed health structure in developing nations, low cost treatment options available, and rise in the new methods like in vitro activation and surrogacy.
Browse Full Report Visit - http://www.acutemarketreports.com/report/global-in-vitro-fertilization-ivf-market-insights-opportunity-analysis-market-shares-and-forecast-2016-2022
The testing and treatment market is growing at a faster rate in males than females. The earlier social taboos among men regarding male fertility have been declining, leading to increase in the male infertility testing and treatment market.
The cost of fertility treatment varies vastly from country to country leading to a rise in medial tourism in relationship with fertility treatments Israel is one of the leading countries with high quality treatments for infertility. The success rate of infertility treatment in Israel is around 46% which in one of the best globally
The companies profile in this report include
1. Merck Sereno
2. Origio
3. Vitrolife AB
4. Axilium Pharma
5. Andology Solutions
6. Auxillum Pharmaceuticals
7. Auxogyn
8. Ferring Pharmaceuticals
9. Genea
10. Helotech DNA
11. Ovascience
2. Origio
3. Vitrolife AB
4. Axilium Pharma
5. Andology Solutions
6. Auxillum Pharmaceuticals
7. Auxogyn
8. Ferring Pharmaceuticals
9. Genea
10. Helotech DNA
11. Ovascience
Browse All Reports of This Category - http://www.acutemarketreports.com/category/healthcare-market
This Acute Market Reports covers1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
This Acute Market Reports covers1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
Chap 1. Executive Summary
Chap 2. Market overview
2.1. Market Share for Drug & Hormone Therapy
2.2. Key buying criteria
2.2.1. Treatment options
2.2.2. Quality of medical procedures
2.2.3. Price of treatments
2.2.4. Shift towards medical tourism
2.2.5. Reimbursement
2.3. Key Findings
2.3.1. highest growth in Male infertility treatment segment
2.3.2. Fertility tourism- The biggest and the growing trend
2.3.3. Upper middle income group is the key target
2.3.4. Regulatory environment key market enabler
2.3.5. Surrogacy preferred for failures in IVF treatments
2.3.6. Technological advancement enhancing success rates of fertility treatments
2.1. Market Share for Drug & Hormone Therapy
2.2. Key buying criteria
2.2.1. Treatment options
2.2.2. Quality of medical procedures
2.2.3. Price of treatments
2.2.4. Shift towards medical tourism
2.2.5. Reimbursement
2.3. Key Findings
2.3.1. highest growth in Male infertility treatment segment
2.3.2. Fertility tourism- The biggest and the growing trend
2.3.3. Upper middle income group is the key target
2.3.4. Regulatory environment key market enabler
2.3.5. Surrogacy preferred for failures in IVF treatments
2.3.6. Technological advancement enhancing success rates of fertility treatments
Chap 3. Male and Female Infertility
3.1. Causes
3.1.1. Causes of male infertility
3.1.1.1. Medical reasons
3.1.1.2. Environmental factors
3.1.1.3. Lifestyle issues
3.1.2. Causes of female infertility
3.1.2.1. Ovulatory disorders
3.1.2.2. Poor functioning or damage to fallopian tube and other issues
3.2. Ethical issues in infertility treatment
3.1. Causes
3.1.1. Causes of male infertility
3.1.1.1. Medical reasons
3.1.1.2. Environmental factors
3.1.1.3. Lifestyle issues
3.1.2. Causes of female infertility
3.1.2.1. Ovulatory disorders
3.1.2.2. Poor functioning or damage to fallopian tube and other issues
3.2. Ethical issues in infertility treatment
Chap 4. Market Determinants
4.1. Market Drivers
4.1.1. Rise in infertility
4.1.2. Fertility Tourism
4.1.3. Surrogacy also responsible for fertility tourism
4.1.4. Technological advancement in healthcare domain
4.1.5. Increase in success rate of treatments
4.1.6. Increasing acceptance of donor eggs by consumers
4.2. Market Restraints
4.2.1. Expensive procedure
4.2.2. Legal issues
4.3. Market Opportunities
4.3.1. Global requirement for low cost instruments and drugs in IVF
4.3.2. IVF an attractive sector for investment for private equity investors
4.3.3. Reproductive tourism
4.4. Market Challenges
4.4.1. Cost barrier for locals in emerging economies
4.4.2. Low acceptance of infertility treatment amongst men
4.4.3. Multiple births and birth defects
4.1. Market Drivers
4.1.1. Rise in infertility
4.1.2. Fertility Tourism
4.1.3. Surrogacy also responsible for fertility tourism
4.1.4. Technological advancement in healthcare domain
4.1.5. Increase in success rate of treatments
4.1.6. Increasing acceptance of donor eggs by consumers
4.2. Market Restraints
4.2.1. Expensive procedure
4.2.2. Legal issues
4.3. Market Opportunities
4.3.1. Global requirement for low cost instruments and drugs in IVF
4.3.2. IVF an attractive sector for investment for private equity investors
4.3.3. Reproductive tourism
4.4. Market Challenges
4.4.1. Cost barrier for locals in emerging economies
4.4.2. Low acceptance of infertility treatment amongst men
4.4.3. Multiple births and birth defects
Chap 5. Market Segmentation
5.1. Male Infertility Market
5.1.1. Male Infertility tests
5.1.1.1. Semen analysis techniques
5.1.1.1.1. CASA provides more accurate results in lesser time
5.1.1.2. DNA fragmentation
5.1.1.2.1. Importance of sperm DNA fragmentation
5.1.1.2.2. When the test is conducted
5.1.1.2.3. Causes of Sperm DNA fragmentation
5.1.1.3. Oxidative Stress Analysis
5.1.1.4. Testicular Biopsy
5.1.1.5. Azoospermia is the reason in 15 percent infertile males
5.1. Male Infertility Market
5.1.1. Male Infertility tests
5.1.1.1. Semen analysis techniques
5.1.1.1.1. CASA provides more accurate results in lesser time
5.1.1.2. DNA fragmentation
5.1.1.2.1. Importance of sperm DNA fragmentation
5.1.1.2.2. When the test is conducted
5.1.1.2.3. Causes of Sperm DNA fragmentation
5.1.1.3. Oxidative Stress Analysis
5.1.1.4. Testicular Biopsy
5.1.1.5. Azoospermia is the reason in 15 percent infertile males
Our Blogs :-
http://www.qyresearchreports.net/
http://www.deepresearchreport.com/
http://www.profresearchreport.com/
http://www.deepresearchreport.com/
http://www.profresearchreport.com/
For Technology News : http://www.mobilecomputingtoday.co.uk/
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
